News
ATRI
583.18
+1.03%
5.93
BRIEF-Atrion Reports Third Quarter 2022 Results
Reuters · 11/08 23:01
Atrion GAAP EPS of $4.94, revenue of $44.63M
Seekingalpha · 11/08 22:54
Atrion Q3 EPS $4.94 Up From $4.58 YoY, Sales $44.63M Up From $42.85M YoY
Benzinga · 11/08 21:39
Atrion Reports Higher Q3 Earnings, Revenue
Atrion Reports Higher Q3 Earnings, Revenue
MT Newswires · 11/08 16:15
-- Earnings Flash (ATRI) ATRION CORPORATION Reports Q3 Revenue $44.6M
-- Earnings Flash (ATRI) ATRION CORPORATION Reports Q3 Revenue $44.6M
MT Newswires · 11/08 16:00
Insider Sell: Atrion
Insider Sell: Atrion
MT Newswires · 10/27 17:48
Declining Stock and Decent Financials: Is The Market Wrong About Atrion Corporation (NASDAQ:ATRI)?
It is hard to get excited after looking at Atrion's (NASDAQ:ATRI) recent performance, when its stock has declined 4.9...
Simply Wall St. · 10/19 16:20
Atrion's (NASDAQ:ATRI) Dividend Will Be Increased To $2.15
The board of Atrion Corporation ( NASDAQ:ATRI ) has announced that it will be increasing its dividend by 10% on the...
Simply Wall St. · 08/26 10:24
BRIEF-Atrion Corporation Announces CFO Succession Plan
BRIEF-Atrion Corporation Announces CFO Succession Plan
Reuters · 08/25 21:49
Atrion gets new finance chief
Atrion (NASDAQ:ATRI) <a href="https://seekingalpha.com/pr/18917846-at...
Seekingalpha · 08/25 21:40
Atrion Says Cindy Ferguson Will Be Next CFO
Atrion Says Cindy Ferguson Will Be Next CFO
MT Newswires · 08/25 17:43
Atrion raises dividend 10.3% to $2.15/share
Atrion (NASDAQ:ATRI) declares <a href="https://seekingalpha.com/pr/18...
Seekingalpha · 08/22 21:24
BRIEF-Atrion Corporation Increases Quarterly Cash Dividend By 10%
BRIEF-Atrion Corporation Increases Quarterly Cash Dividend By 10%
Reuters · 08/22 21:23
Atrion Raises Quarterly Dividend From $1.95/Share To $2.15/Share
Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.95 per share to $2.15 per share. Specifically, the Board of Directors declared a quarterly cash
Benzinga · 08/22 21:23
Earnings Scheduled For August 19, 2022
  Companies Reporting Before The Bell • Hemisphere Media (NASDAQ:HMTV) is projected to report quarterly loss at $0.09 per share on revenue of $52.00 million.
Benzinga · 08/19 09:34
Do Institutions Own Atrion Corporation (NASDAQ:ATRI) Shares?
If you want to know who really controls Atrion Corporation ( NASDAQ:ATRI ), then you'll have to look at the makeup of...
Simply Wall St. · 08/18 11:13
Plurilock Security to buy certain assets of Atrion Communications for $3.7M
Plurilock Security (OTCQB:PLCKF) <a href="https://seekingalpha.com/pr/18897423-plurilocks-aurora-systems-...
Seekingalpha · 08/09 13:18
Atrion GAAP EPS of $5.20, revenue of $48.88M
Atrion press release (NASDAQ:<a href="https://seekingalpha.c...
Seekingalpha · 08/08 21:51
Atrion Posts Higher Q2 Earnings, Revenue
Atrion Posts Higher Q2 Earnings, Revenue
MT Newswires · 08/08 16:11
-- Earnings Flash (ATRI) ATRION CORPORATION Reports Q2 EPS $5.20
-- Earnings Flash (ATRI) ATRION CORPORATION Reports Q2 EPS $5.20
MT Newswires · 08/08 16:04
More
Webull provides a variety of real-time ATRI stock news. You can receive the latest news about Atrion Corp through multiple platforms. This information may help you make smarter investment decisions.
About ATRI
Atrion Corporation is engaged in the development and manufacture of products primarily for medical applications. The Company's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. It has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The Company's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. It also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.